# A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults

> **NCT00938639** · PHASE2 · COMPLETED · sponsor: **Seqirus** · enrollment: 240 (actual)

## Conditions studied

- Influenza Caused by the Novel Influenza A (H1N1) Virus

## Interventions

- **BIOLOGICAL:** CSL425
- **BIOLOGICAL:** CSL425

## Key facts

- **NCT ID:** NCT00938639
- **Lead sponsor:** Seqirus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-09
- **Final completion:** 2010-03
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2018-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00938639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00938639, "A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00938639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*